Department of Pharmacology, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Departments of Pediatrics and Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan; Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu 30010, Taiwan.
Phytomedicine. 2017 Oct 15;34:97-105. doi: 10.1016/j.phymed.2017.08.018. Epub 2017 Aug 18.
Deficiency of survival motor neuron (SMN) protein, which is encoded by the SMN1 and SMN2 genes, induces widespread splicing defects mainly in spinal motor neurons, and leads to spinal muscular atrophy (SMA). Currently, there is no effective treatment for SMA. Liuwei dihuang (LWDH), a traditional Chinese herbal formula, possesses multiple therapeutic benefits against various diseases via modulation of the nervous, immune and endocrine systems. Previously, we demonstrated water extract of LWDH (LWDH-WE) protects dopaminergic neurons and improves motor activity in models of Parkinson's disease.
This study aimed to investigate the potential protection of LWDH-WE on SMN deficiency-induced neurodegeneration and muscle weakness.
The effects of LWDH-WE on SMN deficiency-induced neurotoxicity and muscle atrophy were examined by using SMN-deficient NSC34 motor neuron-like cells and SMA-like mice, respectively.
Inducible SMN-knockdown NSC34 motor neuron-like cells were used to mimic SMN-deficient condition. Doxycycline (1 µg/ml) was used to induce SMN deficiency in stable NSC34 cell line carrying SMN-specific shRNA. SMAΔ7 mice were used as a severe type of SMA mouse model. Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) and lactate dehydrogenase (LDH) assays. Apoptotic cells and neurite length were observed by inverted microscope. Protein expressions were examined by western blots. Muscle strength of animals was evaluated by hind-limb suspension test.
LWDH-WE significantly increased SMN protein level, mitochondrial membrane potential and cell viability of SMN-deficient NSC34 cells. LWDH-WE attenuated SMN deficiency-induced down-regulation of B-cell lymphoma-2 (Bcl-2) and up-regulation of cytosolic cytochrome c and cleaved caspase-3. Moreover, LWDH-WE prevented SMN deficiency-induced inhibition of neurite outgrowth and activation of Ras homolog gene family, member A (RhoA)/ Rho-associated protein kinase (ROCK2)/ phospho-LIM kinase (p-LIMK)/ phospho-cofilin (p-cofilin) pathway. Furthermore, in SMA-like mice, LWDH-WE improved muscle strength and body weight accompanied with up-regulation of SMN protein in spinal cord, brain, and gastrocnemius muscle tissues.
The present study demonstrated that LWDH-WE protects motor neurons against SMN deficiency-induced neurodegeneration, and it also improves the muscle strength of SMA-like mice, suggesting the potential benefits of LWDH-WE as a complementary prescription for SMN deficiency-related diseases.
生存运动神经元(SMN)蛋白的缺乏,由 SMN1 和 SMN2 基因编码,导致广泛的剪接缺陷,主要发生在脊髓运动神经元中,并导致脊髓性肌萎缩症(SMA)。目前,SMA 尚无有效的治疗方法。刘维地黄(LWDH),一种传统的中草药配方,通过调节神经系统、免疫系统和内分泌系统,对多种疾病具有多种治疗益处。先前,我们证明 LWDH 的水提取物(LWDH-WE)可保护多巴胺能神经元并改善帕金森病模型中的运动活动。
本研究旨在探讨 LWDH-WE 对 SMN 缺乏诱导的神经退行性变和肌肉无力的潜在保护作用。
分别使用 SMN 缺陷 NSC34 运动神经元样细胞和 SMA 样小鼠来研究 LWDH-WE 对 SMN 缺乏诱导的神经毒性和肌肉萎缩的影响。
诱导型 SMN 敲低 NSC34 运动神经元样细胞用于模拟 SMN 缺乏状态。使用携带 SMN 特异性 shRNA 的稳定 NSC34 细胞系中的多西环素(1μg/ml)诱导 SMN 缺乏。SMAΔ7 小鼠被用作严重型 SMA 小鼠模型。通过 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴盐(MTT)和乳酸脱氢酶(LDH)测定法测量细胞活力。通过倒置显微镜观察凋亡细胞和神经突长度。通过 Western blot 检测蛋白表达。通过后肢悬挂试验评估动物的肌肉力量。
LWDH-WE 显著增加了 SMN 缺陷 NSC34 细胞的 SMN 蛋白水平、线粒体膜电位和细胞活力。LWDH-WE 减轻了 SMN 缺乏诱导的 B 细胞淋巴瘤-2(Bcl-2)下调和细胞溶质细胞色素 c 和裂解的 caspase-3 上调。此外,LWDH-WE 防止了 SMN 缺乏诱导的神经突生长抑制和 Ras 同源基因家族成员 A(RhoA)/Rho 相关蛋白激酶(ROCK2)/磷酸化 LIM 激酶(p-LIMK)/磷酸化肌动蛋白(p-cofilin)通路的激活。此外,在 SMA 样小鼠中,LWDH-WE 改善了肌肉力量和体重,同时伴有脊髓、大脑和比目鱼肌组织中 SMN 蛋白的上调。
本研究表明,LWDH-WE 可保护运动神经元免受 SMN 缺乏诱导的神经退行性变,还可改善 SMA 样小鼠的肌肉力量,表明 LWDH-WE 作为 SMN 缺乏相关疾病的补充处方具有潜在益处。